02-03-2020 14:00 via medpagetoday.com

EZH2 Functions in Triple-Negative Breast Cancer

]]>(MedPage Today) -- EZH2 (enhancer of zeste homolog 2), a regulator of cell-type identity, is overexpressed in estrogen receptor-negative breast cancer tissues, and associated with metastasis. Celina G. Kleer, MD, director of the breast pathology...
Read more »